DK181084A - Tablet til ph-uafhaengig frigivelse - Google Patents

Tablet til ph-uafhaengig frigivelse Download PDF

Info

Publication number
DK181084A
DK181084A DK181084A DK181084A DK181084A DK 181084 A DK181084 A DK 181084A DK 181084 A DK181084 A DK 181084A DK 181084 A DK181084 A DK 181084A DK 181084 A DK181084 A DK 181084A
Authority
DK
Denmark
Prior art keywords
dipyridamole
acid
independent release
independent
gastrointestinal
Prior art date
Application number
DK181084A
Other languages
English (en)
Other versions
DK166259C (da
DK181084D0 (da
DK166259B (da
Inventor
Jung-Yong Park
Jerzy Debski
Kieran G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of DK181084D0 publication Critical patent/DK181084D0/da
Publication of DK181084A publication Critical patent/DK181084A/da
Publication of DK166259B publication Critical patent/DK166259B/da
Application granted granted Critical
Publication of DK166259C publication Critical patent/DK166259C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK181084A 1983-04-08 1984-04-06 Oral tablet til ph-uafhaengig frigivelse DK166259C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08
US48328583 1983-04-08

Publications (4)

Publication Number Publication Date
DK181084D0 DK181084D0 (da) 1984-04-06
DK181084A true DK181084A (da) 1984-10-09
DK166259B DK166259B (da) 1993-03-29
DK166259C DK166259C (da) 1993-08-23

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
DK181084A DK166259C (da) 1983-04-08 1984-04-06 Oral tablet til ph-uafhaengig frigivelse

Country Status (20)

Country Link
EP (1) EP0121901B1 (da)
JP (1) JPS6034906A (da)
KR (1) KR880002139B1 (da)
AT (1) ATE32980T1 (da)
AU (1) AU570446B2 (da)
CA (1) CA1219216A (da)
DD (1) DD222496A5 (da)
DE (1) DE3469848D1 (da)
DK (1) DK166259C (da)
ES (1) ES531346A0 (da)
FI (1) FI82604C (da)
GR (1) GR81907B (da)
HU (1) HU191542B (da)
IE (1) IE57220B1 (da)
IL (1) IL71458A (da)
NO (1) NO164958C (da)
NZ (1) NZ207768A (da)
PH (1) PH21585A (da)
PT (1) PT78380B (da)
ZA (1) ZA842562B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
KR20080037732A (ko) * 2005-08-22 2008-04-30 노파르티스 아게 ｐＨ-의존성 약물, ｐＨ 개질제 및 지연제를 포함하는제약학적 조성물
EP2101733B1 (en) 2006-12-13 2012-09-26 F. Hoffmann-La Roche AG Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
NO164958B (no) 1990-08-27
KR880002139B1 (ko) 1988-10-17
FI82604B (fi) 1990-12-31
JPH0521892B2 (da) 1993-03-25
AU570446B2 (en) 1988-03-17
IL71458A (en) 1987-09-16
ES8601687A1 (es) 1985-11-01
HU191542B (en) 1987-03-30
FI82604C (fi) 1991-04-10
NO841372L (no) 1984-10-09
NZ207768A (en) 1987-02-20
IE57220B1 (en) 1992-06-03
EP0121901A1 (en) 1984-10-17
DK166259C (da) 1993-08-23
DK181084D0 (da) 1984-04-06
DD222496A5 (de) 1985-05-22
JPS6034906A (ja) 1985-02-22
DE3469848D1 (en) 1988-04-21
ATE32980T1 (de) 1988-04-15
KR840008588A (ko) 1984-12-17
FI841369A0 (fi) 1984-04-06
GR81907B (da) 1984-12-12
IE840856L (en) 1984-10-08
PT78380B (en) 1986-08-14
ZA842562B (en) 1985-12-24
ES531346A0 (es) 1985-11-01
IL71458A0 (en) 1984-07-31
EP0121901B1 (en) 1988-03-16
CA1219216A (en) 1987-03-17
DK166259B (da) 1993-03-29
HUT34345A (en) 1985-03-28
AU2660984A (en) 1984-10-11
FI841369A (fi) 1984-10-09
PH21585A (en) 1987-12-11
PT78380A (en) 1984-05-01
NO164958C (no) 1990-12-05

Similar Documents

Publication Publication Date Title
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
TNSN95076A1 (fr) Forme de dosage ii d'unite multiple en comprime
DE69212882T2 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
FI895342A0 (fi) Ibuprofen-brusprodukter.
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
DE19975062I1 (de) Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
DK166259C (da) Oral tablet til ph-uafhaengig frigivelse
DK209384A (da) 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
ATE15331T1 (de) Verfahren fuer die orale verabreichung von substanzen in der form von liposomen, und ihre pharmazeutischen zusammensetzungen.
GB2051796B (en) (3 - alkylamino - 2 - hydroxypropoxy)-furan - 2 - carboxylic acid anilides and physiologically tolerated acid addition salts thereof processes for their preparation and medicaments containing them
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
IL63683A (en) N-(2-(carboxamino)acetyl))dihydroindole or tetrahydroisoquinoline carboxylic acid derivatives,process for their preparation and pharmaceutical compositions containing same
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
BE862305A (fr) 2-bromo-3-chloro-n-2-imidazolidinylidene-benzamine, ses sels d'addition avec des acides, medicaments la renfermant et procedes pour sa preparation

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK